|
시장보고서
상품코드
1753911
혈관내 가온 시스템 시장 보고서 : 제품 유형, 의료 전문 분야, 용도, 최종사용자, 지역별(2025-2033년)Intravascular Warming Systems Market Report by Product Type, Medical Specialty, Application, End User (Operating Rooms, Intensive Care Units, Emergency Rooms, and Others), and Region 2025-2033 |
||||||
혈관내 가온 시스템 세계 시장 규모는 2024년에 1억 5,320만 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 1억 9,480만 달러에 달할 것으로 예상하며, 2025-2033년 연평균 성장률(CAGR)은 2.57%에 달할 것으로 예측했습니다. 외과 수술의 보급과 의료 산업의 발전이 시장 성장을 촉진하고 있습니다.
정밀 온도 제어에 대한 수요 증가
혈관내 가온 시스템은 환자의 체온을 정확하게 관리함으로써 의료 개입의 정확성에 대한 요구가 높아지는 추세에 대응합니다. 이러한 추세는 다양한 의료 환경에서 환자의 안전성을 높이고 결과를 개선하기 위한 요구에 기인합니다. 예를 들어, 2024년 3월 ZOLL은 Thermogard와 IQool 시스템을 탑재한 첨단 혈관내 가온 시스템을 발표했습니다. 이러한 혁신은 체내 카테터와 체외 패드를 통해 환자의 체온을 관리하고 체간 온도와 체표 온도를 효과적으로 제어하여 정확도와 환자 결과를 개선합니다. 혈관내 가온 시스템 시장 분석 보고서에 따르면, 이는 중요한 성장 촉진요인으로 작용하고 있습니다.
중환자 치료 현장 채용 증가
정상 체온을 유지하고 저체온증을 예방하기 위해 중환자 치료에서 혈관내 가온 시스템의 사용이 증가하고 있습니다. 이러한 추세는 환자의 예후를 개선하고 심각한 상태에서의 합병증을 줄이기 위한 체온 관리의 중요성을 반영하고 있으며, 혈관내 가온 시스템 시장의 수요를 증가시키고 있습니다. 예를 들어, 2024년 3월에는 CHILL-SHOCK 검사가 심인성 쇼크(CS) 환자에서 표적 체온 관리(TTC)의 안전성을 평가했습니다. 이 검사에서 혈관내 가온 시스템은 결과를 개선하고 CS와 관련된 높은 사망률에 대처하기 위한 보조 요법의 가능성에 대해 검토되었습니다.
가온 시스템의 기술적 진보
혈관 내 온열 기술의 혁신은 더 나은 제어, 효율성 및 안전성을 설명합니다. 이러한 발전은 보다 효과적인 환자 치료를 지원하고 전반적인 치료의 질을 향상시키기 위해 의료기기를 개선하는 데 중점을 둔 의료 산업과 일치합니다. 예를 들어, 2024년 1월, 캘리포니아 공과대학은 항생제나 기타 화학적 항균 방법을 사용하지 않고도 박테리아가 업스트림로 이동하는 것을 막는 새로운 유형의 카테터 튜브를 설계했습니다.
The global intravascular warming systems market size reached USD 153.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 194.8 Million by 2033, exhibiting a growth rate (CAGR) of 2.57% during 2025-2033. The increasing prevalence of surgical procedures and advancements in the healthcare industry are stimulating the market growth.
Growing Demand for Precision Temperature Control
Intravascular warming systems enable accurate management of patient temperatures, thereby addressing the increasing need for precision in medical interventions. This trend is driven by the requirement to enhance patient safety and improve outcomes in various healthcare settings. For example, in March 2024, ZOLL introduced advanced intravascular warming systems featuring the Thermogard and IQool systems. These innovations manage patient temperature via internal catheters and external pads, thereby improving precision and patient outcomes by controlling core and surface temperatures effectively. According to the intravascular warming systems market analysis report, this is acting as a significant growth-inducing factor.
Rising Adoption in Critical Care Settings
There is a growing use of intravascular warming systems in critical care to maintain normothermia and prevent hypothermia. This trend reflects the importance of temperature management in improving patient outcomes and reducing complications during critical conditions, thereby elevating the intravascular warming systems market demand. For instance, in March 2024, the CHILL-SHOCK trial assessed the safety of targeted temperature control (TTC) in cardiogenic shock (CS) patients. This study explored intravascular warming systems as potential adjunct therapies to improve outcomes and address high mortality rates associated with CS.
Technological Advancements in Warming Systems
Innovations in intravascular warming technology provide better control, efficiency, and safety. These advancements support more effective patient care and align with the healthcare industry's focus on improving medical devices to enhance overall treatment quality. For example, in January 2024, Caltech designed a new type of catheter tube that impedes the upstream mobility of bacteria without the need for antibiotics or other chemical antimicrobial methods.
According to the intravascular warming systems market forecast report, the segment is driven by the rising requirement for maintaining patient temperature. Convective warming tubing is favored in critical care settings for its efficiency. Water bath warming systems are traditional and widely used, providing consistent heat but with bulkier setups. Heat block warming systems offer precise temperatures.
Intravascular warming systems are crucial across various medical fields, including cardiology, neurology, oncology, orthopedics, and general surgery. They regulate patient temperature during procedures, enhancing safety and outcomes by preventing hypothermia and optimizing therapeutic effectiveness in these diverse specialties.
Perioperative care dominates the intravascular warming systems market share
Perioperative care leads the intravascular warming systems market due to its critical role in maintaining patient normothermia during surgery. Effective temperature management prevents complications like hypothermia, ensuring safer procedures and improved recovery outcomes, driving demand for advanced warming technologies in the operating room.
Operating rooms dominate the market
Operating rooms dominate the intravascular warming systems market, with devices like the arctic sun providing essential temperature regulation during surgeries. This helps ensure patient safety and reduces hypothermia-related complications, thereby leading to their widespread use in surgical settings. This is positively influencing the intravascular warming systems market outlook across the segmentation.
North America dominates the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the intravascular warming systems market outlook report, North America dominates the market driven by advanced healthcare infrastructure and high adoption rates. For instance, systems like the Arctic Sun and Thermogel are extensively used in U.S. hospitals to maintain optimal patient temperatures during surgery. The region's focus on improving surgical outcomes and patient safety further solidifies its dominance, supported by substantial investments in medical technology and growing awareness of hypothermia risks.